You searched for Richter - Page 2 of 14

ASCO 2022: Outcomes Of Richter’s Syndrome In Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Platinum or Anthracycline Based Chemotherapy With or Without a BTK Inhibitor (BTKi)

November 3, 2022

What follows is our patient-friendly summary of this research: Richter’s syndrome (RS), also known as Richter’s transformation, is a rare complication of chronic lymphocytic leukemia (CLL). It transforms into what is usually an aggressive lymphoma with a dismal prognosis.

Announcing the Winner of CLL Society’s First Ever Young Investigator Research Program Award: Dr. Christine Ryan on the Topic of Richter’s Syndrome

August 19, 2022

In January 2022, CLL Society formally announced the launch of a new Research Program that is devoted to supporting underfunded areas of bench and translational science to make progress in the following four critical areas of unmet needs for those diagnosed with CLL / SLL:

ASH 2021: Dr. Nitin Jain on Triple Combination Therapy with Venetoclax, Obinutuzumab, and Atezolizumab for Richter’s Transformation

August 17, 2022

We discuss early results from an ongoing study of a triple combination therapy with a PD-L1 checkpoint inhibitor for treating Richter’s transformation.

ASH 2021: Dr. Alexey Danilov on Richter’s Transformation After CAR-T Therapy

June 9, 2022

and President, interviewed Dr. Alexey Danilov, Associate Director of the Toni Stephenson Lymphoma Center at City of Hope in Duarte, CA. They discussed the development of Richter transformation after chimeric antigen receptor T-cell (CAR-T) therapy.

ASH 2021: Dr. Jennifer Woyach on Predicting Development of Richter’s Syndrome After Ibrutinib Treatment

May 20, 2022

Dr. Mato and Dr. Woyach discusses the results of a study looking at which features might predict the future development of Richter’s syndrome in patients treated with ibrutinib.

Richter’s Transformation

February 11, 2022

Richter’s Transformation Richter’s Transformation First described in 1928, Richter’s Transformation (RT), also called Richter’s Syndrome (RS), occurs when CLL / SLL changes into a related but much more aggressive large cell

ASH 2021: Blinatumomab for Patients with Richter’s Syndrome: A Multicenter Phase 2 Trial from the Filo Group

February 9, 2022

This research was presented by Dr. Romain Guieze and colleagues at the American Society for Hematology annual meeting which was held December 2021 (ASH 2021).

Am I in line for a more aggressive disease journey and possible Richter’s Transformation eventually?

January 12, 2022

Ask the Doctor Question: What prognostic value is exon 15 braf mutation discovery with no tp53, no 17p, no trisonomy 12, no del 11q, but Unmutated status? Am I in line

EHA 2021: Dr. Anthony Mato on Pirtobrutinib (LOXO-305) for Richter’s Transformation in Chronic Lymphocytic Leukemia (CLL)

July 8, 2021

At the annual meeting of the European Hematology Association (EHA) 2021, our own Dr. Brian Koffman interviewed Dr. Anthony Mato, Director of the CLL Program at Memorial Sloan Kettering Cancer Center. They discussed preliminary results from a clinical trial of pirtobrutinib (formerly LOXO-305) in a subset of patients with Richter’s transformation.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Search Results for: Richter – Page 2

ASCO 2022: Outcomes Of Richter’s Syndrome In Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Platinum or Anthracycline Based Chemotherapy With or Without a BTK Inhibitor (BTKi)

Announcing the Winner of CLL Society’s First Ever Young Investigator Research Program Award: Dr. Christine Ryan on the Topic of Richter’s Syndrome

ASH 2021: Dr. Nitin Jain on Triple Combination Therapy with Venetoclax, Obinutuzumab, and Atezolizumab for Richter’s Transformation

ASH 2021: Dr. Alexey Danilov on Richter’s Transformation After CAR-T Therapy

ASH 2021: Dr. Jennifer Woyach on Predicting Development of Richter’s Syndrome After Ibrutinib Treatment

Richter’s Transformation

ASH 2021: Blinatumomab for Patients with Richter’s Syndrome: A Multicenter Phase 2 Trial from the Filo Group

Am I in line for a more aggressive disease journey and possible Richter’s Transformation eventually?

EHA 2021: Dr. Anthony Mato on Pirtobrutinib (LOXO-305) for Richter’s Transformation in Chronic Lymphocytic Leukemia (CLL)

Didn't find what you where looking for?

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT